Stock DNA
Pharmaceuticals & Biotechnology
JPY 48,791 Million (Small Cap)
15.00
NA
0.00%
0.67
24.82%
2.87
Revenue and Profits:
Net Sales:
4,191 Million
(Quarterly Results - Apr 2025)
Net Profit:
782 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-0.59%
0%
-0.59%
6 Months
-27.72%
0%
-27.72%
1 Year
-12.76%
0%
-12.76%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Japan Eyewear Holdings Co. Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
33.10%
EBIT Growth (5y)
72.87%
EBIT to Interest (avg)
12.02
Debt to EBITDA (avg)
1.76
Net Debt to Equity (avg)
0.61
Sales to Capital Employed (avg)
0.53
Tax Ratio
19.79%
Dividend Payout Ratio
39.66%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
18.71%
ROE (avg)
20.87%
Valuation key factors
Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
3.59
EV to EBIT
12.97
EV to EBITDA
9.86
EV to Capital Employed
2.60
EV to Sales
4.14
PEG Ratio
0.24
Dividend Yield
NA
ROCE (Latest)
20.08%
ROE (Latest)
24.32%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Jan'25
Jan'25
Jan'24
Change(%)
Net Sales
16,666.00
13,528.00
23.20%
Operating Profit (PBDIT) excl Other Income
6,996.00
5,278.00
32.55%
Interest
421.00
409.00
2.93%
Exceptional Items
0.00
-113.00
100.00%
Consolidate Net Profit
3,994.00
2,362.00
69.09%
Operating Profit Margin (Excl OI)
319.30%
280.70%
3.86%
USD in Million.
Net Sales
YoY Growth in year ended Jan 2025 is 23.20% vs 26.17% in Jan 2024
Consolidated Net Profit
YoY Growth in year ended Jan 2025 is 69.09% vs 299.66% in Jan 2024
About Japan Eyewear Holdings Co. Ltd. 
Japan Eyewear Holdings Co. Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






